E72.81
Disorders of gamma aminobutyric acid metabolism
Clinical Classification Guidelines
Inclusion Terms
- 4-hydroxybutyric aciduria
- Disorders of GABA metabolism
- GABA metabolic defect
- GABA transaminase deficiency
- GABA-T deficiency
- Gamma-hydroxybutyric aciduria
- SSADHD
- Succinic semialdehyde dehydrogenase deficiency
Medical Intelligence & Overview
Disorders related to gamma-aminobutyric acid (GABA) metabolism are rare genetic conditions that affect how the body processes GABA, an important neurotransmitter in the brain. GABA helps regulate nerve activity, promoting relaxation and inhibiting excessive nerve signals. When its metabolism is disrupted, it can lead to neurological issues characterized by a range of symptoms. This guide offers an overview of these disorders, including causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the enzymes involved in GABA metabolism Inherited patterns passed from parents to children Defects in specific genes responsible for GABA transaminase or succinic semialdehyde dehydrogenase enzymes
Key Symptoms: Developmental delays and intellectual disabilities Seizures or epileptic episodes Muscle weakness or hypotonia (reduced muscle tone) Poor coordination and balance issues Behavioral problems such as irritability or hyperactivity Psychiatric disturbances, including anxiety or depression Sleep disturbances
Diagnostic & Treatment
Diagnosis Path: The diagnosis of GABA metabolism disorders typically involves a combination of clinical evaluation and laboratory testing. Blood and urine tests can detect abnormal levels of GABA and related compounds. Genetic testing may identify specific mutations associated with these conditions. Additionally, neuroimaging studies such as MRI scans can provide supportive information on brain structure and activity. EEGs may be used if seizures are present. Early diagnosis is crucial for managing symptoms effectively.
Treatment Protocols: Current treatment approaches focus on managing symptoms and improving quality of life. Specific therapies may include:
Clinical Advice & FAQs
Billing Guidance
Is E72.81 a billable ICD-10 code?
Yes, E72.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E72.81?
Clinical documentation must specify the nature of Disorders of gamma aminobutyric acid metabolism and any associated comorbidities for accurate reporting.
Cite this Clinical Reference